Diabetic Medicine · 2002 · 324 citations · 25 references
MedicineInternal MedicineNeurologyDiabetologyNeuromuscular DisordersNeuropathologyDiabetes MellitusDiabetic NeuropathyNeurological AssessmentPeripheral Nerve DisordersPeripheral Neuropathy EvaluationSymptom AssessmentClinical Evaluation StandardsConstruct ValidityConstruct Validity AssessmentDiabetic Neuropathy AssessmentNeuropathy Screening InstrumentsNeuropathy Severity ScoringSemmes-weinstein Monofilament TestingVibration Perception Thresholds
AIMS: To provide one of the diagnostic categories for distal diabetic polyneuropathy,several symptom scoring systems are available, which are often extensive and lack in validation. We validated a new four-item Diabetic Neuropathy Symptom (DNS) score for diagnosing distal diabetic polyneuropathy. METHODS: We compared score characteristics of the generally accepted Neuropathy Symptom Score (NSS) with the DNS score, and tested construct validity,predictive value and reproducibility with the Diabetic Neuropathy Examination score, Semmes-Weinstein monofilaments and Vibration Perception Threshold(clinical standards) in 73 patients with diabetes (24 Type 1, 49 Type 2;43 male/30 female; mean age 57 years (19-90);mean diabetes duration 15 years (1-43)). RESULTS: Correlation between NSS and DNS score was high (Spearman r= 0.88). Patient scores were more differentiated on the DNS score. The relation of the NSS and DNS scores, respectively, with clinical standards was good (Spearman r= 0.21-0.60). Reproducibility of the DNS score was high (Cohen weighted kappa 0.78-0.95). The DNS score was easier to perform in clinical practice. CONCLUSIONS: The DNS is validated, fast and easy to perform, with a high predictive value when screening for diabetic polyneuropathy.
25
The Measurement of Observer Agreement for Categorical Data
J. Richard Landis, Gary G. Koch · Biometrics · 1977 · 78.9K citations · Full text
Users' Guides to the Medical Literature
Roman Jaeschke · JAMA · 1994 · 1.1K citations
Medicine, Neurology, Psychiatry +14